08:58:20 EDT Tue 16 Apr 2024
Enter Symbol
or Name
USA
CA



Avricore Health Inc
Symbol AVCR
Shares Issued 94,562,764
Close 2021-07-28 C$ 0.175
Market Cap C$ 16,548,484
Recent Sedar Documents

Avricore, Ellerca to offer joint diabetes screening

2021-07-28 14:37 ET - News Release

Mr. Hector Bremner reports

AVRICORE HEALTH PARTNERS WITH ELLERCA HEALTH INC TO OFFER JOINT DIABETES SCREENING AND MANAGEMENT SUPPORT

Avricore Health Inc. has signed a partnership agreement with Ellerca Health Corp. to utilize their respective technologies and services to offer the most robust diabetes screening and management solutions on the market for community pharmacy.

Avricore Health's objective is to make actionable health information more accessible for everyone by creating the world's largest rapid testing network in pharmacy through HealthTab, its turnkey point-of-care testing solution that effectively turns pharmacies into diagnostic hubs (sometimes known as community diagnostic centres) and connects them on a single cloud-based platform.

Ellerca Health's mission is to improve patient care through leading technologies and innovation. Through the self-management of chronic diseases thanks to a fully supportive digital program, Ellerca Health allows patients to be in control of their own treatment through the 360Care app. Working together with patients in this way reduces the cost and time of reactionary treatment and shifts the focus to preventative care by reducing and eradicating symptoms of chronic conditions.

Ellerca Health's 360Care is an app-based digital platform for chronic disease management that is quickly growing its client base of benefit providers and drug makers to support better patient health outcomes.

Through mutual collaboration on a project-by-project basis, the companies are committed to achieving their shared vision of bringing technologies to community settings that prioritize early detection and screening, along with consistent management of chronic diseases, such as diabetes.

"We believe strongly that co-operation can enhance what we do, and that of those we work with," said Hector Bremner, chief executive officer of Avricore Health. "We've already identified several projects where HealthTab and 360Care can work together to support patient needs in pharmacy, and we look forward to continuing to work towards collaborating on these efforts."

"Working together with Avricore Health will allow our members to have easy access to A1C testing at local pharmacies and improve the speed of results," said Daniel Yeboah, general manager of Ellerca Health. "By bringing critical health data to a patient's mobile device quickly and providing the coaching needed to understand the risks, we can continue to move away from just treating disease and support better health outcomes for people living with chronic conditions, like diabetes."

The companies look forward to jointly pursuing efforts to bring enhanced patient services in community pharmacies that utilize HealthTab's unique diagnostics and data management systems with the continuing coaching and support of 360Care.

About Avricore Health Inc.

Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering, HealthTab (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world's largest network of rapid testing devices in community pharmacies.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.